Search

Search Results
Results 11941 - 11950 of 13351 for Abnormal
  • Clopixol
    Drug - 14 Apr 2026
    Consumer Medicine Information (CMI) about Clopixol intended for persons living in Australia.
  • Bettersizer 2600 Plus particle size and shape analysis system
    Equipment - 13 Apr 2026
    Learn how the Bettersizer 2600 Plus provides comprehensive particle size and shape analysis.
  • Enlafax XR
    Drug - 2 Apr 2026
    Consumer Medicine Information (CMI) about Enlafax XR intended for persons living in Australia.
  • Risperdal Tablets and Solution
    Drug - 4 Mar 2026
    Consumer Medicine Information (CMI) about Risperdal Tablets and Solution intended for persons living in Australia.
  • Efexor XR
    Drug - 12 Feb 2026
    Consumer Medicine Information (CMI) about Efexor XR intended for persons living in Australia.
  • Using BioPALS to study the BRPF1b bromodomain
    White Paper - 10 Oct 2025
    Learn how BioPALS is applied to study the BRPF1b bromodomain.
  • Combining artificial intelligence and biophysics to target BRPF1b
    White Paper - 7 Oct 2025
    Discover how integrating artificial intelligence with biophysical methods enables the identification of novel BRPF1b inhibitors.
  • Monofeme
    Drug - 17 Jul 2025
    Consumer Medicine Information (CMI) about Monofeme intended for persons living in Australia.
  • Loette (New Formulation)
    Drug - 16 Jul 2025
    Consumer Medicine Information (CMI) about Loette (New Formulation) intended for persons living in Australia.
  • Seasonique
    Drug - 17 Dec 2024
    Consumer Medicine Information (CMI) about Seasonique intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback